Lacticaseibacillus rhamnosus GG DSM 33156 effects on pathogen defence in the upper respiratory tract: a randomised, double-blind, placebo-controlled paediatric trial.
Benef Microbes
; 13(1): 13-23, 2022 Feb 28.
Article
in En
| MEDLINE
| ID: mdl-34895109
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Respiratory Tract Infections
/
Probiotics
/
Lacticaseibacillus rhamnosus
Type of study:
Clinical_trials
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adult
/
Child
/
Child, preschool
/
Humans
Language:
En
Journal:
Benef Microbes
Year:
2022
Document type:
Article
Affiliation country:
Denmark
Country of publication:
Netherlands